Non-small cell lung cancer stage iv: Which Medications Are Safest? (161 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
161 medications are used for Non-small cell lung cancer stage iv, with 4,484 combined adverse event reports. The most reported drugs for Non-small cell lung cancer stage iv are PEMBROLIZUMAB and CARBOPLATIN.
4,484
Total Reports
161
Drugs Used
All Medications for Non-small cell lung cancer stage iv Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| PEMBROLIZUMAB | KEYTRUDA | 1,385 | 15,543 | 35,472 | 18.6% |
| CARBOPLATIN | Carboplatin | 1,198 | 12,544 | 35,869 | 14.9% |
| PEMETREXED | Pemetrexed | 782 | 3,876 | 10,697 | 16.5% |
| PACLITAXEL | PACLITAXEL PACLITAXEL | 676 | 12,030 | 31,638 | 15.6% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 488 | 8,520 | 15,094 | 25.3% |
| OSIMERTINIB | TAGRISSO | 404 | 12,456 | 5,277 | 44.9% |
| BEVACIZUMAB | JOBEVNE | 280 | 17,498 | 23,114 | 22.4% |
| CISPLATIN | CISplatin | 222 | 8,387 | 17,469 | 17.7% |
| NIVOLUMAB | OPDIVO | 173 | 23,086 | 36,530 | 26.3% |
| ERLOTINIB | Erlotinib | 168 | 6,791 | 3,693 | 30.2% |
| SOTORASIB | LUMAKRAS | 159 | 700 | 555 | 23.9% |
| CERITINIB | ZYKADIA | 157 | 786 | 804 | 28.1% |
| CRIZOTINIB | Xalkori | 151 | 3,173 | 2,520 | 31.9% |
| DOCETAXEL | Docetaxel | 115 | 6,068 | 13,463 | 9.3% |
| GEFITINIB | Gefitinib | 82 | 1,047 | 853 | 22.3% |
| GEMCITABINE\GEMCITABINE | - | 79 | 2,206 | 3,666 | 21.6% |
| IPILIMUMAB | YERVOY | 79 | 8,043 | 17,031 | 22.0% |
| GEMCITABINE | Gemcitabine | 76 | 5,142 | 12,268 | 16.4% |
| AFATINIB | Gilotrif | 74 | 1,346 | 2,055 | 22.1% |
| DENOSUMAB | Bilprevda | 74 | 19,354 | 17,749 | 13.0% |